Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.5c10240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Marta Serafini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K. Hauptthemen laut MEDLINE: Proteolysis, Cell Cycle Proteins, Transcription Factors, Indolequinones. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Medical Research Council, HORIZON EUROPE European Innovation Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.
- Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K.
- Department of Chemistry & Biochemistry, University of California Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095, United States.
- California NanoSystems Institute, University of California Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, California 90095, United States.
- Jonsson Comprehensive Cancer Center, University of California Los Angeles, 8-684 Factor Building, Los Angeles, California 90095, United States.
- Molecular Biology Institute, University of California Los Angeles, 611 Charles E. Young Drive East, Los Angeles, California 90095, United States.
ORCID-Profile: Marta Serafini, Ewen D D Calder, Ester M Hammond, Stuart J Conway
Förderung
- Engineering and Physical Sciences Research Council
- Medical Research Council
- HORIZON EUROPE European Innovation Council
- University of California, Los Angeles
- Corpus Christi College, University of Cambridge
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Serafini, M., Twigger, S. A., Delfas, G., Mallerman, M., Bailey, E. P., Calder, E. D. D., Hammond, E. M., & Conway, S. J. (2025). Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c10240
Vancouver
Serafini M, Twigger SA, Delfas G, Mallerman M, Bailey EP, Calder EDD, et al. Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c10240
BibTeX
@article{Serafini2025,
author = {Serafini, Marta and Twigger, Sophie A and Delfas, George and Mallerman, Maxim and Bailey, Elliot P and Calder, Ewen D D and Hammond, Ester M and Conway, Stuart J},
title = {Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.5c10240}
}
EUVIMED